AOTMiT: Transparency Council will evaluate drugs for breast cancer, hemophilia and leukemia, among others

The agenda includes:

1. Preparation of a position paper on the evaluation of the drug Altuvoct (efanesoctocog alfa) under the drug program B.15. "Prevention of bleeding in children with hemophilia A and B (ICD-10: D66, D67)".
2. Preparation of a position paper on the evaluation of the drug Phesgo (trastuzumabum + pertuzumabum) under the drug program B.9.FM. "Treatment of patients with breast cancer (ICD-10: C50)".
3. Preparation of a position paper on the evaluation of the drug Blincyto (blinatumomabum) under drug program B.65. "Treatment of patients with acute lymphoblastic leukemia (ICD-10: C91.0)".
4. Preparation of an opinion on the draft health policy program of the local government unit:
   "Health policy program of first aid for students of public secondary schools from the Opolskie district for 2025-2028 "First Aid"".
5. Preparation of an opinion on the draft health policy program of the local government unit:
   "Program for the prevention of depressive disorders among adolescents attending elementary schools, for which the leading body is the City of Ząbki".
6. Preparation of an opinion on the draft health policy program of the local government unit:
   "Health policy program for medical rehabilitation of residents of the Municipality of Inowłódz for 2026-2027".

Source: AOTMiT